Henry Schein (HSIC) stock
Health Care · Health Care Distributors
Henry Schein (HSIC) is a Health Care Distributors company in the Health Care sector, headquartered in Melville, New York. As of October 23, 2026, HSIC closed at $84.96, a market capitalization of $9.47 billion, the 495th largest company in the S&P 500. Over the last twelve months it generated $13.60 billion in revenue (+7% year over year) and $513.00 million in free cash flow. The stock trades at 24.8x trailing earnings and 14.2x forward earnings.
- 1-year total return: +33.6% (dividends reinvested)
- 5-year return: +1.2% a year
- 52-week range: $62.15 – $92.18
- Gross margin 31.3%, operating margin 5.8%
- FI Handbook report card: C+ across 10 metrics
- 60th largest of 60 Health Care stocks in the S&P 500
HSIC price chart
1Y price change: +33.6% (price only; total returns below include dividends)
| Total return | 1M | YTD | 1Y | 3Y | 5Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|
| HSIC | -0.1% | +12.4% | +33.6% | +8.0% | +1.2% | +3.6% | +10.0% |
Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 1995.
HSIC key statistics
- Market cap
- $9.5B
- #495 in S&P 500
- P/E (TTM)
- 24.8x
- Forward P/E
- 14.2x
- EPS (TTM)
- $3.43
- Revenue (TTM)
- $13.6B
- +7%
- Free cash flow
- $513.0M
- Gross margin
- 31.3%
- Operating margin
- 5.8%
- Return on equity
- 8.9%
- Dividend yield
- None
- 52-week range
- $62.15 – $92.18
- Beta
- 0.84
- Price / sales
- 0.7x
- EV / EBITDA
- 13.6x
- Debt / equity
- 0.81x
- Employees
- 25,000
HSIC report card
C+Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.
- Revenue growth6.7%C
- Gross margin31.3%C
- Operating margin5.8%D
- FCF margin3.8%D
- Return on equity8.9%D
- Net debt / EBITDA3.4xD
- Forward P/E14.2xA
- PEG ratio1.7xC
- Shareholder yield9.0%A
- Share count change / yr-3.2%A
Henry Schein financials
Revenue went from $11.6B in fiscal 2016 to $13.2B in fiscal 2025, growing 1.5% a year.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $8.9B | $9.4B | $10.0B | $10.1B | $12.4B | $12.6B | $12.3B | $12.7B | $13.2B |
| Gross profit | $3.2B | $2.7B | $2.9B | $3.1B | $2.8B | $3.7B | $3.8B | $3.9B | $4.0B | $4.1B |
| Operating income | $771.6M | $669.8M | $600.6M | $718.3M | $535.0M | $852.0M | $747.0M | $615.0M | $621.0M | $653.0M |
| Net income | $506.8M | $406.3M | $535.9M | $694.7M | $404.0M | $631.0M | $538.0M | $416.0M | $390.0M | $398.0M |
| EPS (diluted) | $3.10 | $2.57 | $3.49 | $4.65 | $2.82 | $4.45 | $3.91 | $3.16 | $3.05 | $3.27 |
| Free cash flow | $572.4M | $483.1M | $613.4M | $577.9M | $550.0M | $631.0M | $506.0M | $353.0M | $700.0M | $573.0M |
| Buybacks | $550.0M | $450.0M | $200.0M | $525.0M | $74.0M | $401.0M | $485.0M | $250.0M | $385.0M | $850.0M |
| Diluted shares | 163.7M | 158.2M | 153.7M | 149.3M | 143.4M | 141.8M | 137.8M | 131.7M | 127.8M | 121.7M |
Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.
What's priced into HSIC?
A reverse DCF asks what growth the current price requires. With an enterprise value of $13.1B and $513.0M of trailing free cash flow, Henry Schein needs to grow free cash flow about 16.8% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return. For context, free cash flow grew 0.8% a year over the last five years.
P/E ratio history
Current 26.0x vs. median 21.1x (10th–90th percentile 16.4x–27.2x).
A model, not a forecast or advice. Small changes in assumptions move the answer a lot.
HSIC analyst price targets
15 analysts' average 12-month target is $96.87 (+14% vs. $84.96). Targets range from $64.00 to $110.00. 50% rate it a buy.
HSIC earnings
Next report: November 3, 2026. Henry Schein has beaten EPS estimates 4 quarters in a row. Last quarter's revenue was $3.5B (+7% year over year).
| Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Aug 4, 2026 | $1.24 | $1.27 | +2.5% |
| May 5, 2026 | $1.22 | $1.32 | +8.4% |
| Feb 24, 2026 | $1.29 | $1.34 | +3.5% |
| Nov 4, 2025 | $1.28 | $1.38 | +7.9% |
| Aug 5, 2025 | $1.19 | $1.10 | -7.6% |
| May 5, 2025 | $1.11 | $1.15 | +3.6% |
| Feb 25, 2025 | $1.21 | $1.19 | -1.6% |
| Nov 5, 2024 | $1.17 | $1.22 | +4.5% |
Stocks like HSIC
| Name | Today | 1Y | Mkt cap | P/E | |
|---|---|---|---|---|---|
 MCK McKesson | -1.14% | +27% | $116.7B | 26.8x | Compare |
 COR Cencora | -2.21% | +2% | $63.2B | 24.6x | Compare |
 CAH Cardinal Health | -2.37% | +58% | $57.8B | 34.5x | Compare |
 LLY Eli Lilly and | -2.54% | +56% | $1.1T | 42.7x | Compare |
 JNJ Johnson & Johnson | -1.42% | +40% | $635.1B | 40.0x | Compare |
 ABBV AbbVie | +0.16% | +29% | $504.8B | 80.7x | Compare |
 UNH UnitedHealth | -1.62% | +19% | $375.3B | 26.9x | Compare |
 MRK Merck & | -1.34% | +72% | $358.4B | 117.2x | Compare |
HSIC news
- Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET · Oct 20, 2026
- Unpacking Q2 Earnings: Henry Schein (NASDAQ:HSIC) In The Context Of Other Dental Equipment & Technology Stocks · Oct 19, 2026
- What You Need To Know Ahead of Henry Schein's Earnings Release · Oct 16, 2026
- Henry Schein Announces Chief Financial Officer Leadership Transition · Oct 8, 2026
- HSIC or MMSI: Which Is the Better Value Stock Right Now? · Oct 6, 2026
HSIC stock FAQ
What is HSIC's market cap?
Henry Schein's market capitalization is $9.47 billion as of October 23, 2026, ranking 495th in the S&P 500.
What is HSIC's P/E ratio?
HSIC trades at a trailing price-to-earnings ratio of 24.8x and a forward P/E of 14.2x. Its median P/E over the period we track is 21.1x.
Does HSIC pay a dividend?
No. Henry Schein does not currently pay a regular cash dividend.
How much has HSIC stock returned?
Including reinvested dividends, HSIC returned +33.6% over one year, +1.2% a year over five years, +3.6% a year over ten years through October 23, 2026.
Is HSIC stock overvalued?
At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies Henry Schein must grow free cash flow about 17% a year for the next decade. Its free cash flow grew 1% a year over the last five years. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.
What is the HSIC price target?
15 analysts cover HSIC with an average 12-month price target of $96.87, +14% from the current price. 50% of them rate it a buy.
When does HSIC report earnings?
Henry Schein is expected to report earnings on November 3, 2026. It has beaten EPS estimates 4 quarters in a row.
How many employees does Henry Schein have?
Henry Schein has about 25,000 full-time employees, or $544,080 of revenue per employee.
Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology